Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Gallwitz, B.
    Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (2007), Drugs Today, 43, 13-25.
    View publication on PubMed

Application

Application Comment Organism
medicine the DPP-4 inhibitor sitagliptin in diabetes therapy. Sitagliptin is effective, well tolerated and safe in clinical studies. Sitagliptin es effective in monotherapy and combination therapieswith metformin or glitazones. Sitagliptin does not show an increased incidence of hypoglycemic events Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
sitagliptin
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Synonyms

Synonyms Comment Organism
DPP-4
-
Homo sapiens